Submit a notification by the deadline to keep active substances in the GB Review Programme
HSE has published open invitations to provide an opportunity for a person, company or task force/consortium to notify an intention to take up or take over the role of participant in the GB Review Programme for the following active substance/product type combinations.
Anyone wishing to support one of the active substance/product type combinations listed in GB will need to submit a notification to HSE by the following deadline:
15 February 2025
- Reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with bromine and chlorine (DCDMH) (CAS N/A EC N/A) in product type 11
- Reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with chlorine (DCEMH) (CAS 89415-87-2 EC 401-570-7) in product type 11
If a notification to take over the role of participant is not received, these active substance/product type combinations will be subject to a GB non-approval decision. This means the active substances will no longer be able to be used in biocidal products of the relevant product type in GB.
In addition articles treated with such products will no longer be able to be placed on the market in GB. HSE will provide separate updates on these where relevant.
If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of any of the active substance/product type combinations listed above, please contact us.
Take action to keep your active substance in the GB Review Programme
The active substance/product type combinations listed have been successfully notified into the GB Review Programme following open invitations. The next step is for a full active substance dossier to be submitted to HSE by the following deadline:
23 May 2025
- Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvents (redefined from Pyrethrins and Pyrethroids and Chrysanthemum cinerariaefolium, ext.) (CAS 89997-63-7 EC 289-699-3) in product types 18 and 19
Only the person, company or task force/consortium that successfully notified the active substance/product type combinations listed can submit a dossier.
If any of these active substance/product type combinations are important to you, consider contacting the notifier to let them know. You may even be able to join them in supporting the active substance.
Check the list of successful notifiers
If a dossier is not submitted by the deadline, these active substance/product type combinations will be subject to a GB non-approval decision. This means the active substance will no longer be able to be used in biocidal products of the relevant product types in GB.
In addition articles treated with such products will no longer be able to be placed on the market in GB. HSE will provide separate updates on these where relevant.
|
